Literature DB >> 19498433

Pain: Do ACE inhibitors exacerbate complex regional pain syndrome?

David Borsook1, Simona Sava.   

Abstract

Complex regional pain syndrome is a chronic condition arising mainly after tissue injury and involves both inflammatory and neurogenic factors. Use of angiotensin-converting-enzyme inhibitors has been associated with an increased risk of developing the chronic pain condition, which suggests possible roles for substance P and bradykinin in the underlying pathogenic process.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19498433     DOI： 10.1038/nrneurol.2009.73

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  10 in total

1.  The association between ACE inhibitors and the complex regional pain syndrome: Suggestions for a neuro-inflammatory pathogenesis of CRPS.

Authors:  M de Mos; F J P M Huygen; B H Ch Stricker; J P Dieleman; M C J M Sturkenboom
Journal:  Pain       Date:  2009-02-04       Impact factor: 6.961

2.  Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways.

Authors:  Rie Suzuki; Sara Morcuende; Mark Webber; Stephen P Hunt; Anthony H Dickenson
Journal:  Nat Neurosci       Date:  2002-12       Impact factor: 24.884

3.  NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla.

Authors:  Dénes Budai; Sergey G Khasabov; Patrick W Mantyh; Donald A Simone
Journal:  J Neurophysiol       Date:  2006-12-20       Impact factor: 2.714

Review 4.  International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.

Authors:  L M Fredrik Leeb-Lundberg; Francois Marceau; Werner Müller-Esterl; Douglas J Pettibone; Bruce L Zuraw
Journal:  Pharmacol Rev       Date:  2005-03       Impact factor: 25.468

5.  Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods.

Authors:  Emi Fusayasu; Hisanori Kowa; Takao Takeshima; Kazuhiro Nakaso; Kenji Nakashima
Journal:  Pain       Date:  2006-11-22       Impact factor: 6.961

Review 6.  Immune and glial cell factors as pain mediators and modulators.

Authors:  Stephen B McMahon; William B J Cafferty; Fabien Marchand
Journal:  Exp Neurol       Date:  2005-04       Impact factor: 5.330

Review 7.  Complex regional pain syndrome is a disease of the central nervous system.

Authors:  Wilfrid Jänig; Ralf Baron
Journal:  Clin Auton Res       Date:  2002-06       Impact factor: 4.435

8.  Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP.

Authors:  Ulla C Kopp; Michael Z Cicha; Lori A Smith
Journal:  Am J Physiol Renal Physiol       Date:  2003-05-13

9.  Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.

Authors:  Justin L Hay; Jason M White; Felix Bochner; Andrew A Somogyi; Tim J Semple; Bruce Rounsefell
Journal:  J Pain       Date:  2008-12-19       Impact factor: 5.820

10.  Glutamate-mediated astrocyte-neuron signalling.

Authors:  V Parpura; T A Basarsky; F Liu; K Jeftinija; S Jeftinija; P G Haydon
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962
  10 in total
  2 in total

Review 1.  [Complex regional pain syndrome following distal fractures of the radius : Epidemiology, pathophysiological models, diagnostics and therapy].

Authors:  L Harhaus; F Neubrech; C Hirche; T Schilling; H Kohler; A Mayr; A Riesmeier; B Bickert; U Kneser
Journal:  Unfallchirurg       Date:  2016-09       Impact factor: 1.000

2.  Bradykinin Receptors Play a Critical Role in the Chronic Post-ischaemia Pain Model.

Authors:  Elaine C D Gonçalves; Graziela Vieira; Tainara R Gonçalves; Róli R Simões; Indiara Brusco; Sara M Oliveira; João B Calixto; Maíra Cola; Adair R S Santos; Rafael C Dutra
Journal:  Cell Mol Neurobiol       Date:  2020-03-28       Impact factor: 5.046
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.